IPRIPR2024-00260Terminated-Adverse Judgment
Celltrion, Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 11253572.
Type
IPR
Filed
Dec 14, 2023
Instituted
Jan 30, 2024
Decided
Jul 23, 2024
Patent
Application
17352892
Inventor
George YANCOPOULOS
Granted
Feb 22, 2022
01
Timeline
3 milestones
2023-12-14Petition filed
2024-01-30Institution
2024-07-23Terminated
02
Parties & counsel
Petitioner
Celltrion, Inc. et al.
Counsel
Green, Loraet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Brausa, Adamet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →